EA201300358A1 - MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITE - Google Patents
MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITEInfo
- Publication number
- EA201300358A1 EA201300358A1 EA201300358A EA201300358A EA201300358A1 EA 201300358 A1 EA201300358 A1 EA 201300358A1 EA 201300358 A EA201300358 A EA 201300358A EA 201300358 A EA201300358 A EA 201300358A EA 201300358 A1 EA201300358 A1 EA 201300358A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- zeolite
- naphthalan
- refined
- treatment
- inflammatory diseases
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к созданию средства для лечения воспалительных заболеваний опорно-двигательного аппарата на основе рафинированной нефти (нафталана) и цеолита (клиноптилолита). Как средства для лечения заболеваний опорно-двигательного аппарата известны препараты на основе как нафталана, так и цеолита (каждый в отдельности) и используются издавна. Предлагаемое средство содержит: цеолит - 18-25; парафин+воск - 1:1-16-20; морская соль - 3-5; Ag-цеолит - 1-3; рафинированный нафталан - остальное. Сущность предлагаемого изобретения заключается в том, что лекарственные композиции для локального лечения воспалительных заболеваний как суставов и мышц, так и эпидермиса путем введения в заявляемых пределах в состав новых ингредиентов, их количественное соотношение обеспечивают активацию обменных процессов в коже, нормализуют кровоснабжение, ликвидируют застойные явления в зонах воспаления, ускоряют проникновение активных лечебных веществ в пораженные участки, при этом не вызывают аллергического фона.The invention relates to the creation of tools for the treatment of inflammatory diseases of the musculoskeletal system based on refined oil (naphthalan) and zeolite (clinoptilolite). As agents for the treatment of diseases of the musculoskeletal system, preparations based on both naphthalan and zeolite (individually) are known and have been used for a long time. The proposed tool contains: zeolite - 18-25; paraffin wax + 1: 1-16-20; sea salt - 3-5; Ag zeolite 1-3; refined naphthalan - the rest. The essence of the invention lies in the fact that medicinal compositions for the local treatment of inflammatory diseases of both joints and muscles and the epidermis by introducing new ingredients into the claimed limits, their quantitative ratio ensures the activation of metabolic processes in the skin, normalizes blood supply, eliminates stagnation areas of inflammation, accelerate the penetration of active therapeutic substances in the affected areas, while not causing an allergic background.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300358A EA021871B1 (en) | 2012-05-10 | 2012-05-10 | Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300358A EA021871B1 (en) | 2012-05-10 | 2012-05-10 | Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201300358A1 true EA201300358A1 (en) | 2013-11-29 |
EA021871B1 EA021871B1 (en) | 2015-09-30 |
Family
ID=49684442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201300358A EA021871B1 (en) | 2012-05-10 | 2012-05-10 | Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA021871B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2702628C1 (en) * | 2019-03-05 | 2019-10-09 | Общество с ограниченной ответственностью "АрБиПи" | Balneological concentrate composition containing oil of naphthalan refined |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2113855C1 (en) * | 1995-03-01 | 1998-06-27 | Андрей Эдуардович Тараканов | Biologically-active local antiinflammatory and antidegenetarive-dystrophic dough, method of its preparation, species of medicinal plants for it, and method for treatment of inflammatory, denerative-dystrophic diseases of locomotor system |
RU2238099C1 (en) * | 2003-06-18 | 2004-10-20 | Общество с ограниченной ответственностью "Цамакс" | Medicinal agent for treatment of diseases of locomotor system |
RU2416415C1 (en) * | 2010-02-08 | 2011-04-20 | Общество с ограниченной ответственностью "СОЗИДАТЕЛЪ" | Calcium salt agent for treating locomotive diseases in human and animals, including bone fractures and diseases associated with calcium deficiency |
-
2012
- 2012-05-10 EA EA201300358A patent/EA021871B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA021871B1 (en) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017002767A1 (en) | New specific proteins for cd137. | |
PH12016502254A1 (en) | Keratin treatment formulations and methods | |
EA201790195A1 (en) | METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS | |
BR112015006828A8 (en) | compound, or a pharmaceutically acceptable salt thereof; pharmaceutical composition; use of the compound; and method for modulating the activity of an ire1 protein | |
MX2017010697A (en) | Mixed allergen compositions and methods for using the same. | |
BR112014008700A2 (en) | compositions useful in the treatment of nephropathy and processes for preparing same | |
PE20180399A1 (en) | TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE OF THE SAME | |
CL2021000207A1 (en) | New fusion proteins specific for cd137 and pd-l1 | |
EA201390826A1 (en) | PYRIMIDINOUS CONNECTIONS FOR USE IN TREATING DISEASES OR STATES MEDIATED BY Lp-PLA | |
FR3034993B1 (en) | UNIT PACKAGING, COMPOSITIONS AND THERAPEUTIC DIAGRAMS FOR THE ADMINISTRATION OF PRO-RESOLUTION PATHWAY STIMULATORS ON KERATINIC SURFACES | |
BR112017026535A2 (en) | compound of formula I, isolated enantiomer, pharmaceutical composition, method for inhibiting mct4 monocarboxylate transporter activity, method for selectively inhibiting mct4 monocarboxylate transporter activity, method for treating a mct4 monocarboxylate transporter mediated disorder and use of a compound | |
BR112019017393A8 (en) | Pharmaceutical composition of evolocumab and its use, kit, method for preparing pcsk9-binding polypeptide and method for formulating therapeutic polypeptide | |
AR094851A1 (en) | BICYCLIC COMPOUNDS AS S1P₁ AGONISTS | |
EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
BR112013011064A2 (en) | nutraceutical or oral cosmetic use and oral cosmetic treatment process | |
UA112418C2 (en) | THERAPEUTIC DISEASE | |
EA201300358A1 (en) | MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITE | |
WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
BR112022003639A8 (en) | BIO-STIMULATING AGENT FOR TREATMENT OF PLANTS AND/OR PLANT SEEDS | |
BR112015022025A8 (en) | composition and use of an active agent | |
MX2015008676A (en) | Metadichol r liquid and gel nanoparticle formulations. | |
BR112016028561A2 (en) | composition, dosage form, and methods for reducing the risk for mortality in an individual, the risk for a disease or condition in an individual, triglycerides in an individual's blood, an individual's resting heart rate, lipoprotein cholesterol non-high density in an individual, total cholesterol in an individual, apolipoprotein b in an individual blood, systolic blood pressure in an individual, and diastolic blood pressure in an individual, to prolong an individual's life, to treat hypertriglyceridemia in an individual and to increase an omega-3 index in an individual's red blood cells. | |
EA201400703A1 (en) | MEDICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PSORIASIS | |
WO2023041524A3 (en) | Compositions and methods for treating synucleinopathies | |
EA202092554A1 (en) | COMPOSITIONS FOR TREATMENT OF SKIN DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |